Investigators tested whether avian-derived polymerase genes allow influenza to replicate at temperatures higher than those preferred by human seasonal strains. Avian influenza replicates in the gut at roughly 41°C; human upper-respiratory replication occurs near 33°C. The authors hypothesized that acquisition of an avian PB1 gene could permit replication at febrile temperatures seen in infected humans. Using a mini-replicon system, the study team reported that a seasonal human H1N1 polymerase failed to produce viral RNA efficiently at 40°C. When the seasonal polymerase’s PB1 was substituted with PB1 from the 1918, 1957, or 1968 pandemic viruses — each of which carried an avian-origin PB1 — RNA synthesis at 40°C was restored. The authors also tested a PB1 from a low-pathogenic avian H2N1 virus and observed a similar restorative effect. These cell-based data indicate a direct link between PB1 origin and polymerase performance at elevated temperatures.
The researchers did not rely solely on cell assays. They purified chimeric IAV polymerase complexes and measured enzymatic activity in vitro. Activity assays with these purified polymerases suggested that the avian-origin PB1 subunit itself may intrinsically enhance polymerase function at elevated temperatures, rather than effects being driven only by host factors. In other words, the polymerase complex containing an avian PB1 showed greater RNA synthesis activity at 40°C relative to the seasonal human polymerase counterpart. The paper states that PB1, as the catalytic core of the heterotrimeric RNA-dependent RNA polymerase, is essential for viral RNA synthesis — and that modifying this subunit alters temperature-dependent activity.
To connect biochemical observations to authentic infection, the study team generated chimeric seasonal H1N1 viruses expressing avian or 1918 PB1 and infected MDCK cells. The chimeric viruses replicated at 40°C in MDCK culture, whereas the wild-type seasonal H1N1 failed to do so. These infection experiments provide a functional demonstration that PB1 origin can determine the ability of an otherwise human-adapted virus to replicate under febrile conditions. The authors note that fever elevates body temperature to 38°C or above and can restrict viral replication; their data position avian-origin PB1 as one viral factor capable of overcoming this barrier.
The study team connects these mechanistic findings to historical pandemics: the 1918, 1957, and 1968 pandemic IAV strains each acquired an avian-origin PB1 gene, a pattern that may reflect selective advantage during cross-species adaptation. Data indicated that acquisition of an avian PB1 enables temperature-resistant genome replication — a property that could help avian-derived viruses replicate in febrile mammalian hosts and therefore support zoonotic establishment and spread. Based on their results, the authors suggest that molecular surveillance focused on avian-origin PB1 genes in IAVs detected in mammals could help identify viruses with increased pandemic potential and inform countermeasure development. The keywords the authors attached to the work include host temperature, influenza A, replication fitness, RNA-dependent RNA polymerase, and virus-host interactions.
The authors acknowledge that the adaptive advantage conferred by avian-origin PB1 genes has not been fully resolved; their experiments identify temperature-resistant replication as a plausible mechanism but do not provide a complete evolutionary or host-range account. The paper reports observations from mini-replicon systems, purified polymerase activity assays, and MDCK cell infections; the source did not report in vivo mammalian host experiments or epidemiological quantification of how frequently avian PB1 acquisitions drive zoonotic events. The authors recommend surveillance of avian-origin PB1 genes in IAVs circulating in mammals as a practical next step. Remaining questions include the broader genetic context required for PB1-mediated adaptation and how host immune responses interact with PB1-dependent temperature resilience. These unresolved issues — explicitly noted in the abstract — define concrete research priorities going forward.